USA
News & Media
Take a closer look at what we’re doing across Teva worldwide
Press releases
Jun 19 / 2019
Teva Announces Launch of a Generic Version of Tracleer® (bosentan) Tablets in the United States
Jun 10 / 2019
Teva Pharmaceuticals USA, Inc. Expands Voluntary Nationwide Recall of Losartan Potassium to 50 mg and 100 mg Tablets USP, Sold Exclusively to Golden State Medical Supply, Inc.
May 29 / 2019
Teva to present new fremanezumab FOCUS Clinical Study Data for the first time at the 13th European Headache Federation Congress
Teva presents 17 posters and three oral presentations at EHF 2019 highlighting long-term and FOCUS Phase IIIb study data The poster presentations highlight FOCUS data in migraine patients who have failed two to four classes of prior migraine preventive medications; as well as present further clinical study data regarding the efficacy and safety results of fremanezumab through 12 months of treatment in patients with chronic and episodic migraine
May 28 / 2019
Teva Announces Launch of a Generic Version of Ranexa® (ranolazine) Extended-Release Tablets in the United States
Top Stories
Read the latest Teva news
21 Jun 2019
Celebrating Pride Month At Teva
Teva’s Pride Employee Resource (ERG) group members reflect on the role the Stonewall Uprising played in their own lives and the important mission of the ERG for fostering a culture of inclusion.
Kathleen Veit
HBA National Rising Star
